Result of WRAP Retail Offer
MedPal AI Plc has successfully concluded its WRAP Retail Offer, raising approximately £105,160, and has secured an additional £300,000 through a subscription agreement, both at a price of 2.5 pence per new ordinary share. Combined with the previously announced £527,000 from a placing, the company has raised a total of £932,160. A total of 16,206,396 new ordinary shares will be issued, and admission to trading on AIM is expected around March 26, 2026, at which point the company's total issued ordinary share capital will be 492,441,036 shares.
Select text to share a quote on X · sign in to keep highlights & notes in your MPAL notes
Further to its announcement of 20 March 2026, MedPal AI plc (AIM: MPAL, FRA:Z1N), the UK digital health and AI company, is pleased to confirm the result of its WRAP Retail Offer ("WRAP"). The WRAP Retail Offer has raised gross proceeds of approximately £105,160. In addition the Company has entered into a subscription agreement to raise a further £300,000 at 2.5p per share (the "Subscription"). With the proceeds of the Placing of £527,000 announced on 20 March 2026, in aggregate the Company has therefore raised gross proceeds of approximately £932,160 at a price of 2.5 pence per new ordinary share. The Company will issue 16,206,396 new Ordinary Shares ("Fundraise Shares") in respect of the WRAP and the Subscription.
Admission and Total Voting Rights
Application has been made for the Fundraise Shares to be admitted to trading on AIM along with the Placing Shares ("Admission"). Admission is expected to become effective and dealings in the shares are expected to commence on or around 26 March 2026.
Upon Admission, the Company's issued ordinary share capital will consist of 492,441,036 Ordinary Shares with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, from Admission the total number of Ordinary Shares and voting rights in the Company will be 492,441,036. With effect from Admission, this figure may be used by Shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
The new Ordinary Shares to be issued pursuant to the Placing, Subscription and WRAP Retail Offer will be issued free of all liens, charges and encumbrances and will, on Admission, rank pari passu in all respects with the Company's existing Ordinary Shares.
Capitalised terms used but not defined in this announcement have the same meaning as set out in the Company's announcement released on 20 March 2026.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.